STAT Plus: Suddenly, the Bristol-Celgene deal is looking shaky. What might be next for Celgene?
ALEX HOGAN/STAT
Two big shareholders, Wellington Management and Starboard, now say they oppose the Bristol-Celgene deal.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario